Literature DB >> 4798183

Effects of lipid removal on the molecular size and kinetic properties of bovine plasma arylesterase.

B J Kitchen, C J Masters, D J Winzor.   

Abstract

A purified arylesterase preparation from bovine plasma was characterized to the extent that it has a partial specific volume of 0.91ml/g and an apparent z-average molecular weight of 440000. The relatively large magnitude of the former reflects the presence of phospholipids, cholesterol, triglycerides and beta-carotene, the last-named being responsible for the pronounced yellow colour of the preparation. Removal of the lipid material is accompanied by a decrease in the apparent z-average molecular weight to 120000, the size of the smallest species detected by high-speed sedimentation equilibrium being in the vicinity of 70000 daltons: denaturation of the lipid-free preparation with 6m-guanidine hydrochloride caused essentially complete breakdown into subunits of this size. In kinetic studies on the enzyme the maximal velocity for the hydrolysis of phenyl acetate was found to increase by 60% on addition of 1 mm-Ca(2+), with the K(m) showing a concomitant decrease from 6.6 to 2.1 mm. Removal of lipid had no detectable effect on V(max.) or K(m) in either the presence or the absence of Ca(2+). It is concluded that the bovine plasma arylesterase preparation is either a lipoprotein or an enzyme-lipoprotein complex with properties very similar to those of the alpha(1)-lipoprotein or high-density lipoprotein (HDL(2)) fraction of serum.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4798183      PMCID: PMC1165793          DOI: 10.1042/bj1350093

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  19 in total

1.  C-and N-terminal amino acids of human serum lipoproteins.

Authors:  B SHORE
Journal:  Arch Biochem Biophys       Date:  1957-09       Impact factor: 4.013

2.  Serum esterases. I. Two types of esterase (A and B) hydrolysing p-nitrophenyl acetate, propionate and butyrate, and a method for their determination.

Authors:  W N ALDRIDGE
Journal:  Biochem J       Date:  1953-01       Impact factor: 3.857

Review 3.  Microdetermination of vitamin A and carotenoids in blood and tissue.

Authors:  D S McLaren; W W Read; Z L Awdeh; M Tchalian
Journal:  Methods Biochem Anal       Date:  1967

4.  The carbohydrate components of rat serum lipoproteins.

Authors:  J B Marsh; R Fritz
Journal:  Proc Soc Exp Biol Med       Date:  1970-01

5.  Molecular weight interrelationships in the vertebrate esterases.

Authors:  N Kingsbury; C J Masters
Journal:  Biochim Biophys Acta       Date:  1970-01-20

6.  Are serum lipoproteins esterases? Esterase activity of the immunoprecipitates of duck-serum high-density lipoprotein in agar immunoelectrophoresis and immunodiffusion.

Authors:  M Kaminski; P Dubois
Journal:  Eur J Biochem       Date:  1972-08-18

7.  Quantitative analysis of serum lipids with thin-layer chromatography.

Authors:  J Gloster; R F Fletcher
Journal:  Clin Chim Acta       Date:  1966-02       Impact factor: 3.786

8.  The gel-filtration behaviour of proteins related to their molecular weights over a wide range.

Authors:  P Andrews
Journal:  Biochem J       Date:  1965-09       Impact factor: 3.857

9.  Forms of human serum high density lipoprotein protein.

Authors:  A Scanu
Journal:  J Lipid Res       Date:  1966-03       Impact factor: 5.922

10.  Estimation of the molecular weights of proteins by Sephadex gel-filtration.

Authors:  P Andrews
Journal:  Biochem J       Date:  1964-05       Impact factor: 3.766

View more
  11 in total

1.  Activity of esterases in plasma from Ghanaian and British subjects.

Authors:  F M Williams; E N Nicholson; N W Woolhouse; K K Adjepon-Yamoah; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

2.  Plasma esterase activity in patients with aspirin-sensitive asthma or urticaria.

Authors:  F M Williams; S I Asad; M H Lessof; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

3.  Paraoxon hydrolysis in human serum mediated by a genetically variable arylesterase and albumin.

Authors:  J Ortigoza-Ferado; R J Richter; S K Hornung; A G Motulsky; C E Furlong
Journal:  Am J Hum Genet       Date:  1984-03       Impact factor: 11.025

4.  The human serum paraoxonase/arylesterase polymorphism.

Authors:  H W Eckerson; C M Wyte; B N La Du
Journal:  Am J Hum Genet       Date:  1983-11       Impact factor: 11.025

5.  Further evidence for the concept of bovine plasma arylesterase as a lipoprotein.

Authors:  M M Don; C J Masters; D J Winzor
Journal:  Biochem J       Date:  1975-12       Impact factor: 3.857

6.  Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.

Authors:  M Aviram; M Rosenblat; C L Bisgaier; R S Newton; S L Primo-Parmo; B N La Du
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

7.  Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression.

Authors:  V H Brophy; R L Jampsa; J B Clendenning; L A McKinstry; G P Jarvik; C E Furlong
Journal:  Am J Hum Genet       Date:  2001-05-02       Impact factor: 11.025

8.  Effects of cumin extract on oxLDL, paraoxanase 1 activity, FBS, total cholesterol, triglycerides, HDL-C, LDL-C, Apo A1, and Apo B in in the patients with hypercholesterolemia.

Authors:  Keihan Ghatreh Samani; Effat Farrokhi
Journal:  Int J Health Sci (Qassim)       Date:  2014-01

9.  Role of genetic polymorphism of human plasma paraoxonase/arylesterase in hydrolysis of the insecticide metabolites chlorpyrifos oxon and paraoxon.

Authors:  C E Furlong; R J Richter; S L Seidel; A G Motulsky
Journal:  Am J Hum Genet       Date:  1988-09       Impact factor: 11.025

10.  Association of adiponectin, leptin and resistin with inflammatory markers and obesity in dementia.

Authors:  Małgorzata Bednarska-Makaruk; Ałła Graban; Anna Wiśniewska; Wanda Łojkowska; Anna Bochyńska; Magdalena Gugała-Iwaniuk; Ksenia Sławińska; Agnieszka Ługowska; Danuta Ryglewicz; Hanna Wehr
Journal:  Biogerontology       Date:  2017-04-18       Impact factor: 4.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.